424 related articles for article (PubMed ID: 10471610)
1. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
Tanaka E; Kimoto T; Tsuyuguchi K; Watanabe I; Matsumoto H; Niimi A; Suzuki K; Murayama T; Amitani R; Kuze F
Am J Respir Crit Care Med; 1999 Sep; 160(3):866-72. PubMed ID: 10471610
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
Wallace RJ; Brown BA; Griffith DE; Girard WM; Murphy DT
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1766-72. PubMed ID: 8665032
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
[TBL] [Abstract][Full Text] [Related]
4. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
[TBL] [Abstract][Full Text] [Related]
5. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
6. The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
Kadota JI; Kurashima A; Suzuki K
J Infect Chemother; 2017 May; 23(5):293-300. PubMed ID: 28254517
[TBL] [Abstract][Full Text] [Related]
7. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Kobashi Y; Matsushima T
Intern Med; 2003 Aug; 42(8):670-5. PubMed ID: 12924489
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
[TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
[TBL] [Abstract][Full Text] [Related]
11. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
Sato K; Ebe T
Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
[TBL] [Abstract][Full Text] [Related]
13. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
Griffith DE; Brown BA; Cegielski P; Murphy DT; Wallace RJ
Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330
[TBL] [Abstract][Full Text] [Related]
14. [Outcome of pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin (CAM)-containing regimens].
Shirai M; Hayakawa H; Nakano Y; Kuroishi S; Nakano Y; Todate A; Suda T; Chida K
Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):875-9. PubMed ID: 15566000
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
[TBL] [Abstract][Full Text] [Related]
18. A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements.
Burman WJ; Reves RR; Rietmeijer CA; Cohn DL
Int J Tuberc Lung Dis; 1997 Apr; 1(2):163-9. PubMed ID: 9441082
[TBL] [Abstract][Full Text] [Related]
19. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
Fujita M; Kajiki A; Tao Y; Miyazaki M; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
J Infect Chemother; 2012 Apr; 18(2):146-51. PubMed ID: 21927844
[TBL] [Abstract][Full Text] [Related]
20. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
Ito Y; Miwa S; Shirai M; Kanai M; Fujita K; Ohba H; Iwaizumi E; Oshima T; Kojima S; Suda T; Hayakawa H
Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
